ANXIETY is the #9 most commonly reported adverse reaction for DOCETAXEL ANHYDROUS, manufactured by Hospira, Inc.. There are 3,451 FDA adverse event reports linking DOCETAXEL ANHYDROUS to ANXIETY. This represents approximately 2.3% of all 152,096 adverse event reports for this drug.
Patients taking DOCETAXEL ANHYDROUS who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
ANXIETY3,451 of 152,096 reports
ANXIETY is a less commonly reported adverse event for DOCETAXEL ANHYDROUS, but still significant enough to appear in the safety profile.
Other Side Effects of DOCETAXEL ANHYDROUS
In addition to anxiety, the following adverse reactions have been reported for DOCETAXEL ANHYDROUS:
ANXIETY has been reported as an adverse event in 3,451 FDA reports for DOCETAXEL ANHYDROUS. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is ANXIETY with DOCETAXEL ANHYDROUS?
ANXIETY accounts for approximately 2.3% of all adverse event reports for DOCETAXEL ANHYDROUS, making it a notable side effect.
What should I do if I experience ANXIETY while taking DOCETAXEL ANHYDROUS?
If you experience anxiety while taking DOCETAXEL ANHYDROUS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.